A Randomized, Double Blind, Placebo-controlled Study to Assess the the Preemptive Benefit of Etoricoxib in Patients Receiving Anterior Cruciate Ligament Reconstruction

Phase 4 Completed 64 enrolled National Taiwan University Hospital Merck Sharp & Dohme LLC · collab

RandomizedParallel-groupTriple-blindTreatment

Summary

Post surgical pain associated with ligament reconstruction may persist for few days after the surgical procedure. Arcoxia is a new anti-inflammatory and analgesic drug that alleviate pain through oral administration. This study will test the safety and efficacy of Arcoxia in the management of post-operational pain in patients receive the ligament reconstruction surgery.

Timeline

Start: 2008-05
Primary completion: 2010-06
Completion: 2010-06

Drugs

Evaluation	Drug	Modality	Dose	Route
Comparator	Etoricoxib	Small molecule	90 mg	Oral

Indications

No indication recorded.